Cancer Victims Urge Court to End J&J Bankruptcy Roadblock to Lawsuits September 22, 2022 By Dietrich Knauth People suing Johnson & Johnson over the company’s talc products urged an appeals court on Monday to revive their claims,...
J&J to End Global Sales of Talc-Based Baby Powder August 12, 2022 By Ankur Banerjee Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two...
Director of 9/11 Fund Picked to Estimate Cost of J&J Talc Claims July 29, 2022 By Steven Church The lawyer who oversaw payments to victims of the Sept. 11 terrorist attacks will be appointed by a federal judge...
Johnson & Johnson Acquires Oklahoma’s Midlands Management WB&B and MGU Units June 7, 2022 Johnson & Johnson acquired the assets of the wholesale brokerage & binding (WB&B) and managing general underwriting (MGU) units of...
California Appeals Court Says J&J Must Pay $302M in Pelvic Mesh Case April 14, 2022 A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay penalties to the state...
Johnson & Johnson Can’t Block Lawsuit Claiming It Lied About Asbestos in Talc April 13, 2022 By Steven Church Johnson & Johnson can’t use its baby powder bankruptcy to prevent a lawsuit that accuses the company of hiding evidence...
Johnson & Johnson to Suspend Supply of Personal Care Products to Russia March 29, 2022 Johnson & Johnson said on Tuesday it would halt sale of personal care products in Russia, joining other companies that...
J&J’s Victory Over Cancer Victims Clears Path for 3M, Others March 25, 2022 By Jef Feeley and Steven Church A court ruling allowing Johnson & Johnson to use a controversial bankruptcy strategy to force cancer victims into potential settlement...
J&J’s Controversial Prison Testing Resurfaces in Baby Powder Lawsuits March 8, 2022 By Jef Feeley More than 50 years ago, nearly a dozen men incarcerated outside of Philadelphia enrolled in an experiment funded by Johnson...
Illinois Expects $760 Million From Opioid Settlement March 1, 2022 Illinois is expected to receive $760 million as part of a settlement with pharmaceutical distributors sued for their role in...